Suppr超能文献

耻骨后根治性前列腺切除术后顺行注射胶原蛋白治疗压力性尿失禁的长期疗效

Long-term results after antegrade collagen injection for stress urinary incontinence following radical retropubic prostatectomy.

作者信息

Klutke J J, Subir C, Andriole G, Klutke C G

机构信息

Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, USA.

出版信息

Urology. 1999 May;53(5):974-7. doi: 10.1016/s0090-4295(98)00621-9.

Abstract

OBJECTIVE

To evaluate the long-term success of antegrade collagen injection in men with stress urinary incontinence after radical prostatectomy.

METHODS

Between October 1994 and January 1996, 20 patients underwent antegrade collagen injection for stress urinary incontinence caused by radical prostatectomy. Evaluation by pad test, urodynamics, and subjective scores was performed before and after injection.

RESULTS

At a mean follow-up of 28 months, 10% of the patients were cured and 35% were improved. All patients received a single treatment (mean total volume of collagen injected 14.5 mL). In 11 patients without long-term improvement, 2 had undergone irradiation previously and 7 had failed retrograde collagen injections. Two patients with vesical neck contracture were successfully treated. Preoperative incontinence severity and stress leak point pressure did not correlate with failure.

CONCLUSIONS

A 45% cured or improved rate at long-term follow-up is possible in men with stress incontinence after radical prostatectomy using a single antegrade collagen injection. Although antegrade delivery of collagen for stress incontinence minimized short-term, technique-related failures, for a substantial number of patients therapy had failed at long-term follow-up.

摘要

目的

评估顺行性胶原蛋白注射治疗根治性前列腺切除术后男性压力性尿失禁的长期疗效。

方法

1994年10月至1996年1月期间,20例因根治性前列腺切除术导致压力性尿失禁的患者接受了顺行性胶原蛋白注射治疗。在注射前后通过尿垫试验、尿动力学和主观评分进行评估。

结果

平均随访28个月时,10%的患者治愈,35%的患者病情改善。所有患者均接受了单次治疗(胶原蛋白平均注射总量为14.5 mL)。在11例未获得长期改善的患者中,2例曾接受过放疗,7例逆行性胶原蛋白注射治疗失败。2例膀胱颈挛缩患者得到成功治疗。术前尿失禁严重程度和压力性漏尿点压力与治疗失败无关。

结论

对于根治性前列腺切除术后压力性尿失禁的男性患者,单次顺行性胶原蛋白注射治疗在长期随访中可能有45%的治愈率或改善率。虽然顺行性注射胶原蛋白治疗压力性尿失禁可将短期技术相关失败率降至最低,但在大量患者的长期随访中治疗仍告失败。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验